Efficacy of atomoxetine in adult attention-Deficit/hyperactivity disorder: A drug-placebo response curve analysis

Behavioral and Brain Functions

Volumn 1, Issue , 2005, Pages

  Faraone, Stephen V ^a   Biederman, Joseph ^b   Spencer, Thomas ^b   Michelson, David ^c   Adler, Lenard ^d   Reimherr, Fred ^e   Glatt, Stephen J ^f  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; PLACEBO;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 33745287595     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-1-16     Document Type: Article

References (13)

1. Fuller R, Wong D: Effects of antidepressants on uptake and receptor systems in the brain. Prog Neuro-Psychopharmacol & Biol Psychiat 1985, 9:485-490.
2. Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, Harding M, Faraone SV, Seidman L: Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry 1998, 155:693-695.
3. Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D: Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003, 53:112-120.
4. Wernicke JF, Kratochivil C: Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. Journal of Clinical Psychiatry 2002, 63:50-55.
5. Faraone SV, Biederman J, Spencer TJ, Wilens TE: The drug-placebo response curve: a new method for assessing drug effects in clinical trials. Journal of Clinical Psychopharmacology 2000, 20:673-679.
6. McNeil BJ, Hanley JA: Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med Dec Making 1984, 4:137-150.
7. Swets JA: Sensitivities and specificities of diagnostic tests. JAMA 1982, 248:548-549.
8. Siegel B, Vukicevic J, Spitzer RL: Using signal detection methodology to revise DSM-III-R: Re-analysis of the DSM-III-R national field trials for autistic disorder. Journal of Psychiatric Research 1990, 24:293-311.
9. Siegel B, Vukicevic J, Elliott GR, Kraemer HC: The use of signal detection theory to assess DSM-III-R criteria for autistic disorder. J Am Acad Child Adolesc Psychiatry 1989, 28:542-548.
10. Faraone SV, Pliszka SR, Olvera RL, Skolnik R, Biederman J: Efficacy of adderall and methylphenidate in attention-deficit/hyperactivity disorder: a drug-placebo and drug-drug response curve analysis. Journal of Child and Adolescent Psychopharmacology 2001, 11:171-180.
11. Faraone SV, Short E, Biederman J, Findling RL, Roe CM, Manos M: Efficacy of Adderall and Methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. International Journal of Neuropsychopharmacology 2002, 5:121-129.
12. Colditz GA, Miller JN, Mosteller F: Measuring gain in the evaluation of medical technology. The probability of a better outcome. Int J Technol Assess Health Care 1988, 4:637-642.
13. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.